Merus N.V

+0.71 (+3.38%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)865.86M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$7.92 Million
Adjusted EPS-$0.59
See more estimates
10-Day MA$21.84
50-Day MA$22.10
200-Day MA$19.03
See more pivots

Merus N.V Stock, NASDAQ:MRUS

Yalelaan 62, Yalelaan 62, Utrecht, Utrecht 3584 CM
Phone: +
Number of Employees:


Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.